Instil Bio Stock Buy Hold or Sell Recommendation
| TIL Stock | USD 10.84 0.37 3.53% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Instil Bio is 'Hold'. The recommendation algorithm takes into account all of Instil Bio's available fundamental, technical, and predictive indicators you will find on this site.
Check out Instil Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide. Note, we conduct extensive research on individual companies such as Instil and provide practical buy, sell, or hold advice based on investors' constraints. Instil Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Instil |
Execute Instil Bio Buy or Sell Advice
The Instil recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Instil Bio. Macroaxis does not own or have any residual interests in Instil Bio or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Instil Bio's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Very Weak | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Above Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Very Weak | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Instil Bio Trading Alerts and Improvement Suggestions
| Instil Bio generated a negative expected return over the last 90 days | |
| Instil Bio has high likelihood to experience some financial distress in the next 2 years | |
| Reported Net Loss for the year was (156.09 M) with profit before taxes, overhead, and interest of 138 K. | |
| Instil Bio has about 354.61 M in cash with (82.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.73. | |
| Instil Bio has a very weak financial position based on the latest SEC disclosures | |
| Roughly 65.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Long Term Investment Analysis - Stock Traders Daily |
Instil Bio Returns Distribution Density
The distribution of Instil Bio's historical returns is an attempt to chart the uncertainty of Instil Bio's future price movements. The chart of the probability distribution of Instil Bio daily returns describes the distribution of returns around its average expected value. We use Instil Bio price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Instil Bio returns is essential to provide solid investment advice for Instil Bio.
| Mean Return | -0.12 | Value At Risk | -3.28 | Potential Upside | 4.15 | Standard Deviation | 2.27 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Instil Bio historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Instil Stock Institutional Investors
| Shares | Geode Capital Management, Llc | 2024-03-31 | 34.8 K | Millennium Management Llc | 2024-03-31 | 31.4 K | Two Sigma Advisers, Llc | 2024-03-31 | 29.5 K | Squarepoint Ops Llc | 2024-03-31 | 17.4 K | State Street Corporation | 2024-03-31 | 11.7 K | Acadian Asset Management Llc | 2024-03-31 | 10.2 K | Morgan Stanley - Brokerage Accounts | 2024-03-31 | 5.6 K | Barclays Plc | 2024-03-31 | 479 | Tower Research Capital Llc | 2024-03-31 | 274 | Curative Ventures V Llc | 2023-12-31 | 1.9 M | Vivo Capital, Llc | 2024-03-31 | 624.3 K |
Instil Bio Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Instil Bio or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Instil Bio's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Instil stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.13 | |
β | Beta against NYSE Composite | 0.74 | |
σ | Overall volatility | 2.21 | |
Ir | Information ratio | -0.06 |
Instil Bio Volatility Alert
Instil Bio exhibits very low volatility with skewness of 0.39 and kurtosis of -0.57. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Instil Bio's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Instil Bio's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Instil Bio Fundamentals Vs Peers
Comparing Instil Bio's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Instil Bio's direct or indirect competition across all of the common fundamentals between Instil Bio and the related equities. This way, we can detect undervalued stocks with similar characteristics as Instil Bio or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Instil Bio's fundamental indicators could also be used in its relative valuation, which is a method of valuing Instil Bio by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Instil Bio to competition |
| Fundamentals | Instil Bio | Peer Average |
| Return On Equity | -0.48 | -0.31 |
| Return On Asset | -0.13 | -0.14 |
| Current Valuation | (691.03 K) | 16.62 B |
| Shares Outstanding | 6.5 M | 571.82 M |
| Shares Owned By Insiders | 6.84 % | 10.09 % |
| Shares Owned By Institutions | 65.37 % | 39.21 % |
| Number Of Shares Shorted | 8.74 K | 4.71 M |
| Price To Earning | 18.31 X | 28.72 X |
| Price To Book | 0.31 X | 9.51 X |
| Price To Sales | 55,330 X | 11.42 X |
| Gross Profit | 138 K | 27.38 B |
| EBITDA | (85.78 M) | 3.9 B |
| Net Income | (156.09 M) | 570.98 M |
| Cash And Equivalents | 354.61 M | 2.7 B |
| Cash Per Share | 2.73 X | 5.01 X |
| Total Debt | 86.05 M | 5.32 B |
| Debt To Equity | 0.12 % | 48.70 % |
| Current Ratio | 8.51 X | 2.16 X |
| Book Value Per Share | 31.65 X | 1.93 K |
| Cash Flow From Operations | (82.03 M) | 971.22 M |
| Short Ratio | 0.70 X | 4.00 X |
| Earnings Per Share | (18.97) X | 3.12 X |
| Target Price | 20.33 | |
| Number Of Employees | 49 | 18.84 K |
| Beta | 1.18 | -0.15 |
| Market Capitalization | 67.25 M | 19.03 B |
| Total Asset | 325.63 M | 29.47 B |
| Retained Earnings | (580.98 M) | 9.33 B |
| Working Capital | 150.2 M | 1.48 B |
| Net Asset | 325.63 M |
Note: Disposition of 1192729 shares by Curative Ventures V Llc of Instil Bio subject to Rule 16b-3 [view details]
Instil Bio Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Instil . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Instil Bio Buy or Sell Advice
When is the right time to buy or sell Instil Bio? Buying financial instruments such as Instil Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 35.8M | 28.0M | 7.6M | 7.2M | Total Assets | 610.0M | 482.1M | 325.6M | 384.2M |
Use Investing Ideas to Build Portfolios
In addition to having Instil Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Aggressive Funds Thematic Idea Now
Aggressive Funds
Funds or Etfs that attempt to achieve high capital gains by investing in companies with high growth potential and above average risk. The Aggressive Funds theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aggressive Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Information and Resources on Investing in Instil Stock
When determining whether Instil Bio is a strong investment it is important to analyze Instil Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Instil Bio's future performance. For an informed investment choice regarding Instil Stock, refer to the following important reports:Check out Instil Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Instil Bio. If investors know Instil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Instil Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (18.97) | Return On Assets (0.13) | Return On Equity (0.48) |
The market value of Instil Bio is measured differently than its book value, which is the value of Instil that is recorded on the company's balance sheet. Investors also form their own opinion of Instil Bio's value that differs from its market value or its book value, called intrinsic value, which is Instil Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Instil Bio's market value can be influenced by many factors that don't directly affect Instil Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Instil Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instil Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Instil Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.